"Immunization, Passive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER).
| Descriptor ID |
D007116
|
| MeSH Number(s) |
E02.095.465.425.400.330 E05.478.550.520
|
| Concept/Terms |
Immunization, Passive- Immunization, Passive
- Immunizations, Passive
- Passive Immunization
- Passive Immunizations
Passive Antibody Transfer- Passive Antibody Transfer
- Antibody Transfer, Passive
- Antibody Transfers, Passive
- Passive Antibody Transfers
- Transfer, Passive Antibody
- Transfers, Passive Antibody
- Passive Transfer of Immunity
Immunotherapy, Passive- Immunotherapy, Passive
- Passive Immunotherapy
- Immunotherapies, Passive
- Passive Immunotherapies
Immunoglobulin Therapy- Immunoglobulin Therapy
- Therapy, Immunoglobulin
- Immunoglobulin Therapies
- Therapies, Immunoglobulin
|
Below are MeSH descriptors whose meaning is more general than "Immunization, Passive".
Below are MeSH descriptors whose meaning is more specific than "Immunization, Passive".
This graph shows the total number of publications written about "Immunization, Passive" by people in this website by year, and whether "Immunization, Passive" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 1 | 3 |
| 1995 | 1 | 1 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 1 | 2 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 2 | 0 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 1 | 2 |
| 2016 | 0 | 1 | 1 |
| 2020 | 0 | 4 | 4 |
| 2021 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunization, Passive" by people in Profiles.
-
Human Anti-neuraminidase Antibodies Reduce Airborne Transmission of Clinical Influenza Virus Isolates in the Guinea Pig Model. J Virol. 2022 01 26; 96(2):e0142121.
-
Early Convalescent Plasma for High-Risk Outpatients with Covid-19. N Engl J Med. 2021 11 18; 385(21):1951-1960.
-
Target specific serologic analysis of COVID-19 convalescent plasma. PLoS One. 2021; 16(4):e0249938.
-
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults. Trials. 2021 Mar 20; 22(1):221.
-
Extracorporeal Membrane Oxygenation for COVID-19-Associated Multisystem Inflammatory Syndrome in a 5-year-old. Am Surg. 2022 Feb; 88(2):174-176.
-
Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial. J Intern Med. 2021 04; 289(4):559-573.
-
Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome. Pediatr Blood Cancer. 2020 11; 67(11):e28693.
-
COVID-19 convalescent plasma donor recruitment: beware the Faustian bargains. Transfusion. 2020 07; 60(7):1643-1644.
-
Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance. J Virol. 2019 02 15; 93(4).
-
Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo. Science. 2016 May 20; 352(6288):1001-4.